ArticleRespiratory research2026
A deep learning model based on ultrasound imaging to differentiate malignant from benign pleural effusion: a multicenter cohort study.
Article in Respiratory research, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundThoracentesis is required for malignant pleural effusion (MPE) diagnosis. However, it is an invasive procedure and carries risks. It remains unknown whether deep learning using ultrasound images could become a non-invasive diagnostic approach.
methodsPatients with pleural effusion detected by thoracic ultrasound and received diagnostic thoracentesis were retrospectively collected from two sites. The internal cohort collected patients from the National Taiwan University Hospital (NTUH) Hsin-Chu branch (2014–2021), whereas the external cohort collected patients from NTUH (2020–2021). The MPE was confirmed by cytopathology reports, while benign pleural effusion was ascertained by negative cytology and compatible clinical courses. A convolutional deep learning model was used to identify MPE. Performance metrics included accuracy, F1 score, sensitivity, specificity and the area under the receiver operating characteristic curve (AUC).
resultsA total of 601 and 144 patients from the internal cohort and the external cohort were used for model development. The model achieved promising results in internal testing (accuracy = 0.750 [95% CI: 0.689–0.811], sensitivity = 0.710 [95% CI: 0.619–0.798], specificity = 0.803 [95% CI: 0.704–0.893], F1 = 0.763 [95% CI: 0.691–0.826], AUC = 0.814 [95% CI: 0.746─0.873]). After fine-tuning with small number of external images, the model achieved the following performance on the external testing set: accuracy = 0.774 [95% CI: 0.679–0.857], sensitivity = 0.818 [95% CI: 0.723–0.905)], specificity = 0.611 [95% CI: 0.389–0.846], F1 = 0.850 [95% CI: 0.776–0.913], AUC = 0.753 [95% CI: 0.596–0.885].
conclusionsOur deep learning model holds promise as a non-invasive point-of-care modality for assistance in pleural effusion diagnosis.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.